http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0612397-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2006-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3333bcc2aa2271cbffb25f6d97a411d |
| publicationDate | 2011-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0612397-A2 |
| titleOfInvention | use of azd2171 or a pharmaceutically acceptable salt thereof and gemcitabine, pharmaceutical composition, kit, and method for producing an anti-angiogenic and / or vascular permeability reducing effect in a warm-blooded animal |
| abstract | USE OF AZD2 171 OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND GENCITABINE, PHARMACEUTICAL COMPOSITION, KIT, AND, METHOD FOR THE PRODUCTION OF AN ANTI-ANGIOGENIC EFFECT AND / OR REDUCER OF VASCULAR PERMEABILITY IN A BLOOD ANIMAL. The present invention relates to a method for producing an anti-angiogenic and / or reducing effect on vascular permeability in a warm-blooded animal such as a human being being optionally treated with ionizing radiation, particularly a method for the treatment a cancer, particularly a cancer involving a solid tumor, which comprises administering AZD2171 in combination with gemcitabine; for a pharmaceutical composition comprising AZD2171 and gemcitabine; for a combination product comprising AZD2171 and gemcitabine for use in a method of treating the body of a human or animal by therapy; for a kit comprising AZD2171 and gemcitabine; for the use of AZD2171 and gemcitabine in the manufacture of a medicine for use in producing an anti-angiogenic and / or reducing effect on vascular permeability in a warm-blooded animal such as a human being being optionally treated with ionizing radiation. |
| priorityDate | 2005-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.